Open access
Oct 2026
Real-world outcomes of atezolizumab plus bevacizumab in patients with hepatocellular carcinoma: A retrospective cohort study
Real-world data confirm the efficacy and manageable toxicity of atezolizumab plus bevacizumab plus bevacizumab in HCC patients in a real-world single-center setting.
I. A. Filippov, E. A. Gaisina, M. S. Shvedsky et al.
· Meditsinskiy sovet = Medical... · 0 citations